S&P 500   3,347.14 (-0.77%)
DOW   29,030.63 (-0.65%)
QQQ   231.95 (-1.21%)
AAPL   317.09 (-1.00%)
MSFT   180.37 (-2.20%)
GOOGL   1,501.98 (-0.99%)
AMZN   2,118.22 (-1.62%)
BABA   214.12 (-1.80%)
TSLA   900.47 (+0.12%)
AMD   55.35 (-3.35%)
DIS   139.45 (-0.66%)
S&P 500   3,347.14 (-0.77%)
DOW   29,030.63 (-0.65%)
QQQ   231.95 (-1.21%)
AAPL   317.09 (-1.00%)
MSFT   180.37 (-2.20%)
GOOGL   1,501.98 (-0.99%)
AMZN   2,118.22 (-1.62%)
BABA   214.12 (-1.80%)
TSLA   900.47 (+0.12%)
AMD   55.35 (-3.35%)
DIS   139.45 (-0.66%)
S&P 500   3,347.14 (-0.77%)
DOW   29,030.63 (-0.65%)
QQQ   231.95 (-1.21%)
AAPL   317.09 (-1.00%)
MSFT   180.37 (-2.20%)
GOOGL   1,501.98 (-0.99%)
AMZN   2,118.22 (-1.62%)
BABA   214.12 (-1.80%)
TSLA   900.47 (+0.12%)
AMD   55.35 (-3.35%)
DIS   139.45 (-0.66%)
S&P 500   3,347.14 (-0.77%)
DOW   29,030.63 (-0.65%)
QQQ   231.95 (-1.21%)
AAPL   317.09 (-1.00%)
MSFT   180.37 (-2.20%)
GOOGL   1,501.98 (-0.99%)
AMZN   2,118.22 (-1.62%)
BABA   214.12 (-1.80%)
TSLA   900.47 (+0.12%)
AMD   55.35 (-3.35%)
DIS   139.45 (-0.66%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 NeoGenomicsBlueprint MedicinesHUTCHISON CHINA/SDeciphera PharmaceuticalsAdaptive Biotechnologies
SymbolNASDAQ:NEONASDAQ:BPMCNASDAQ:HCMNASDAQ:DCPHNASDAQ:ADPT
Price Information
Current Price$32.45$65.20$26.19$55.79$33.98
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$24.67$104.08$27.91$62.23$43.00
% Upside from Price Target-23.99% downside59.64% upside6.57% upside11.54% upside26.55% upside
Trade Information
Market Cap$3.60 billion$3.56 billion$3.66 billion$2.81 billion$4.17 billion
Beta1.031.650.792.04N/A
Average Volume709,485962,350330,417495,1001,541,844
Sales & Book Value
Annual Revenue$276.74 million$66.51 million$214.11 millionN/A$55.66 million
Price / Sales12.2452.9716.32N/A75.91
Cashflow$0.30 per shareN/AN/AN/AN/A
Price / Cash106.55N/AN/AN/AN/A
Book Value$3.43 per share$8.59 per share$3.10 per share$7.43 per shareN/A
Price / Book9.467.598.45N/A
Profitability
Net Income$2.64 million$-347,690,000.00$-74,810,000.00$-99,850,000.00$-46,450,000.00
EPS$0.13($7.27)($0.57)($2.82)N/A
Trailing P/E Ratio3,248.25N/AN/AN/A0.00
Forward P/E Ratio111.90N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins0.55%-522.75%N/AN/AN/A
Return on Equity (ROE)4.60%-72.52%N/A-46.67%N/A
Return on Assets (ROA)3.07%-49.72%N/A-42.10%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.24%0.19%0.01%N/AN/A
Current Ratio4.24%4.85%2.63%15.20%8.20%
Quick Ratio4.05%4.85%2.48%15.20%8.08%
Ownership Information
Institutional Ownership Percentage83.22%N/A29.95%73.06%65.84%
Insider Ownership Percentage8.80%4.02%N/A7.02%34.70%
Miscellaneous
Employees1,500217714112346
Shares Outstanding104.41 million54.03 million133.38 million51.04 million124.34 million
Next Earnings Date2/27/2020 (Confirmed)5/14/2020 (Estimated)3/3/2020 (Confirmed)3/12/2020 (Estimated)2/26/2020 (Confirmed)
OptionableOptionableOptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel